Jane Street’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Jane Street’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-563	Closed	-$79K	–	11045
2021 Q3	$79K	Buy	+563	New	+$112K	﹤0.01%	9391
2021 Q2	–	Sell	-624	Closed	-$134K	–	10652
2021 Q1	$134K	Sell	624 -242	-28%	-$66.9K	﹤0.01%	8514
2020 Q4	$209K	Buy	+866	New	+$107K	﹤0.01%	6905
2019 Q2	–	Sell	-911	Closed	-$146K	–	5937
2019 Q1	$146K	Sell	911 -78	-8%	-$15.4K	﹤0.01%	4716
2018 Q4	$257K	Buy	989 +108	+12%	+$21.7K	﹤0.01%	4234
2018 Q3	$215K	Sell	881 -460	-34%	-$120K	﹤0.01%	4605
2018 Q2	$316K	Buy	+1,341	New	+$391K	﹤0.01%	4067

Other funds holding EVLO

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jane Street's EVLO Position: Q4 2021 in Review

Jane Street sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2021, closing a stake of 563 shares — an estimated $79K sold.

Jane Street first reported a position in EVLO in Q2 2018 and held it in 7 quarters. The position peaked at $316K in Q2 2018. 66 funds tracked by Wall St. Rank hold EVLO as of Q4 2021.

Jane Street reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Jane Street sold 563 Evelo Biosciences, Inc. Common Stock shares in Q4 2021, an estimated $79K.
Jane Street first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 7 quarters.
Jane Street's Evelo Biosciences, Inc. Common Stock position peaked at $316K in Q2 2018.
66 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2021.

Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.